Nicotine
Smoking Cessation Aid
Mechanism
Nicotine binds to and activates nicotinic acetylcholine receptors (nAChRs), which are ligand-gated cation channels located at autonomic ganglia, the neuromuscular junction, and throughout the CNS. In the brain, it preferentially activates α4β2 nAChR subtypes on dopaminergic neurons in the ventral tegmental area, stimulating dopamine release in the nucleus accumbens — the neural substrate of its addictive properties. At low doses it stimulates ganglionic transmission; at high doses it produces depolarization block, causing ganglionic paralysis.
Indications
Dosing
- Adult
- effective dose and for the shortest time possible, with a regular review at least every 6 weeks. h In patients who have dementia with Lewy bodies or Parkinson’s disease dementia, antipsychotic drugs can worsen the motor features of the condition, and in some cases cause severe antipsychotic sensitivity reactions. See also management of psychotic symptoms in Parkinson’s disease p. 429.…
Pharmacokinetics
Contraindications
- Avoid alkaline solutions during gastric lavage for poisoning
- Cardiac arrhythmias
- Ischaemic heart disease
Side effects
- Faintness
- Prostration
- Fall in blood pressure
- Difficult breathing
- Weak, rapid, and irregular pulse
- Collapse
- Terminal convulsions
- Death (within a few minutes from respiratory failure, at acutely fatal doses of about 60 mg in adults)
- Tolerance
- Dependence
- Vasospastic angina may be precipitated
Related guidelines
Other Smoking Cessation Aid drugs
Ask House about Nicotine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, BNF·Verified: 2026-05-13 · House clinical team